-
Mashup Score: 09 Top Applications of Artificial Intelligence in Business - 3 year(s) ago
Enterprise use of AI is increasing and expanding into new areas. Read about nine top applications of AI in business and the benefits they bring companies.
Source: SearchEnterpriseAICategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Peter Hulick posted on LinkedIn - 3 year(s) ago
Sign in or join now to see posts like this one and more.
Source: www.linkedin.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @ph4235: Expanding the team! #hiring #genomics #personalisedmedicine NorthShore University HealthSystem https://t.co/6UsUkUGfNr
-
-
Mashup Score: 2First-Line Encorafenib, Binimetinib, and Cetuximab Combination Provides Clinical Benefit and Manageable Safety in BRAF V600E–Mutated mCRC - 3 year(s) ago
BRAF V600E mutations are identified in 8 to 15% of patients with metastatic colorectal cancer and represent a subtype that carries a poor prognosis
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
1st-line #encorafenib, #binimetinib, & #cetuximab combination provides clinical benefit & manageable safety in patients with BRAF V600E mutated #metastaticcolorectalcancer 👉https://t.co/So2aUkXGA2 #colorectalcancer #personalisedmedicine #WorldGI2021 #mCRC https://t.co/7jVv1iAquA
-
-
Mashup Score: 3Trastuzumab Deruxtecan Demonstrates Efficacy in HER2-positive and HER2-low Advanced Gastric Cancer - 3 year(s) ago
Findings from a post-hoc exploratory biomarker analysis of DESTINY-Gastric01 study
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Trastuzumab deruxtecan demonstrates efficacy in #HER2-positive & #HER2-low adv #gastriccancer: Findings from post-hoc exploratory #biomarker analysis of DESTINY-Gastric01 study 👉 https://t.co/IvAH6zB01a #personalisedmedicine #gastrointestinalcancers #WorldGI2021 @KoheiShitara https://t.co/BN8FPqVmll
-
-
Mashup Score: 0Despite success of targeted therapies, personalised medicine is not yet a reality in ovarian cancer - 3 year(s) ago
Expert says widely applicable predictive testing is needed to improve prevention, diagnosis and treatment
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Personalisedmedicine is not yet a reality in #ovariancancer. Dr Domenica Lorusso, #ESMOGynae21 Co-Chair: widely applicable predictive testing is needed to improve prevention, diagnosis and treatment. https://t.co/7wON8pqnF2 #ESMOperspectives #gyncsm #ovca
-
-
Mashup Score: 0NRG1 Fusion–positive Lung Cancers are Molecularly, Pathologically, and Clinically More Heterogeneous than Previously Thought - 3 year(s) ago
Findings from the eNRGy1 global multicentre registry
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NRG1 Fusion–positive #LungCancers are molecularly, pathologically, and clinically more heterogeneous than previously thought: Findings from the eNRGy1 global multicentre registry 📑 https://t.co/UNWRCVXGxY #oncologynews #lcsm #personalisedmedicine https://t.co/PfiztHeWxF
-
-
Mashup Score: 5Maintenance Rucaparib for Platinum-Sensitive Pancreatic Adenocarcinoma with HRD-Associated Mutations - 3 year(s) ago
Results of a phase II study in patients with germline or somatic pathogenic variants in BRCA1/2 or PALB2
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Maintenance rucaparib for platinum-sensitive pancreatic adenocarcinoma w/ HRD-associated mutations: Results of a ph II study in #cancer pts w/ germline or somatic pathogenic variants in BRCA1/2 or PALB2 🔎https://t.co/lIo83F5fBx #pancsm #personalisedmedicine #pancreaticcancer https://t.co/lCZDNJz5ke
-
-
Mashup Score: 0
Drug response differs substantially in cancer patients due to inter- and intra-tumor heterogeneity. Particularly, transcriptome context, especially tumor microenvironment, has been shown playing a significant role in shaping the actual treatment outcome. In this study, we develop a deep variational autoencoder (VAE) model to compress thousands of genes into latent vectors in a low-dimensional…
Source: www.nature.comCategories: Cardiologists, Latest HeadlinesTweet-
Deep generative neural network for accurate drug response imputation https://t.co/nYeXIeOPBW #genetics #digitalhealth #personalisedmedicine #precisionmedicine @nature
-
-
Mashup Score: 2Squamous Cell Carcinoma of the Head and Neck | ESMO - 3 year(s) ago
Squamous Cell Carcinoma of the Head and Neck: ESMO Clinical Practice Guidelines
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Squamous cell carcinoma of oral cavity, larynx, oropharynx & hypopharynx: EHNS-ESMO-ESTRO Guidelines for clinical & pathological diagnosis, staging & risk assessmt, treatmt, follow-up & #personalisedmedicine options https://t.co/qu5wjy6YSq @EHNSnews @ESTRO_RT @Annals_Oncology https://t.co/G5zRLuQZ7f
-
-
Mashup Score: 1FDA Approves Companion Diagnostic to Identify NTRK Fusions in Solid Tumours for Larotrectinib - 4 year(s) ago
NGS-based test identifies fusions in NTRK genes in DNA isolated from tumour tissue specimens
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
FDA approves companion diagnostic to identify #NTRK fusions in solid tumours for Larotrectinib: #nextgenerationsequencing -based test identifies fusions in NTRK genes in DNA isolated from tumour tissue specimens 👉https://t.co/qqCe6rmFsi #oncologynews #personalisedmedicine https://t.co/u6e9kDIop3
-
#artificialintelligence in #healthcare: #research analyzing vast #data collected to uncover patterns and insights. #algorithms in diagnostic tools for clinicians #decisionsupport. #personalisedmedicine developing more individualized treatment plans. https://t.co/piEgNkrnfw